Malaria vaccines the continuing quest
"In 2013, 200 million people were infected with malaria, resulting in over 584,000 deaths, with the potential to affect over half the world's population. Such is the widespread nature of malaria that it is increasingly believed only a vaccine will lead to its eradication. Although the firs...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
London
World Scientific Publishing Europe Ltd
c2016
|
| Schlagworte: | |
| Online-Zugang: | FHN01 URL des Erstveroeffentlichers |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044633150 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 171120s2016 |||| o||u| ||||||eng d | ||
| 020 | |a 9781786340054 |c ebook |9 978-1-78634-005-4 | ||
| 024 | 7 | |a 10.1142/Q0002 |x Verlag |z URL des Erstveroeffentlichers |3 Volltext |2 doi | |
| 035 | |a (ZDB-124-WOP)0000Q0002 | ||
| 035 | |a (OCoLC)988734640 | ||
| 035 | |a (DE-599)BVBBV044633150 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-92 | ||
| 082 | 0 | |a 616.9/362061 |2 23 | |
| 100 | 1 | |a Sherman, Irwin W. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Malaria vaccines |b the continuing quest |c Irwin W. Sherman |
| 264 | 1 | |a London |b World Scientific Publishing Europe Ltd |c c2016 | |
| 300 | |a 1 online resource (278 p.) |b ill. (some col.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from PDF file title page (viewed May 25, 2016) | ||
| 520 | |a "In 2013, 200 million people were infected with malaria, resulting in over 584,000 deaths, with the potential to affect over half the world's population. Such is the widespread nature of malaria that it is increasingly believed only a vaccine will lead to its eradication. Although the first attempt at a vaccine was made a century ago, it is only in the last 30 years that real progress in testing has been made, in the hope of discovering a molecule that can provide long-lasting protection against the disease. In July 2015, GlaxoSmithKline (GSK) announced that after 30 years of research it had received the green light from the European Medicines Agency for the world's first malaria vaccine, RTS, S, for use in African children aged 6 weeks to 17 months. This book chronicles the development of RTS, S — done in collaboration with the Walter Reed Army Institute for Research, the PATH Malaria Vaccine Initiative (MVI) and funded in part by the Bill and Melinda Gates Foundation — as well as previous candidate vaccines. It also focusses on the continuing quest to find more effective vaccines against this continuing health crisis. Finally, it provides an easily understood background on recombinant DNA and monoclonal antibodies and places them in perspective to their contributions to malaria vaccine development. This book serves as a convenient and easily accessible source of information for students, teachers, microbiologists, parasitologists, physicians, clinicians and research funders."--Provided by publisher | ||
| 650 | 4 | |a Malaria vaccine | |
| 650 | 4 | |a Malaria / Treatment | |
| 650 | 4 | |a Electronic books | |
| 856 | 4 | 0 | |u http://www.worldscientific.com/worldscibooks/10.1142/Q0002 |x Verlag |z URL des Erstveroeffentlichers |3 Volltext |
| 912 | |a ZDB-124-WOP | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030031122 | ||
| 966 | e | |u http://www.worldscientific.com/worldscibooks/10.1142/Q0002 |l FHN01 |p ZDB-124-WOP |q FHN_PDA_WOP |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804178043375190016 |
|---|---|
| any_adam_object | |
| author | Sherman, Irwin W. |
| author_facet | Sherman, Irwin W. |
| author_role | aut |
| author_sort | Sherman, Irwin W. |
| author_variant | i w s iw iws |
| building | Verbundindex |
| bvnumber | BV044633150 |
| collection | ZDB-124-WOP |
| ctrlnum | (ZDB-124-WOP)0000Q0002 (OCoLC)988734640 (DE-599)BVBBV044633150 |
| dewey-full | 616.9/362061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9/362061 |
| dewey-search | 616.9/362061 |
| dewey-sort | 3616.9 6362061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02930nmm a2200385zc 4500</leader><controlfield tag="001">BV044633150</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">171120s2016 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781786340054</subfield><subfield code="c">ebook</subfield><subfield code="9">978-1-78634-005-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1142/Q0002</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveroeffentlichers</subfield><subfield code="3">Volltext</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-124-WOP)0000Q0002</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)988734640</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044633150</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9/362061</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sherman, Irwin W.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Malaria vaccines</subfield><subfield code="b">the continuing quest</subfield><subfield code="c">Irwin W. Sherman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">World Scientific Publishing Europe Ltd</subfield><subfield code="c">c2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (278 p.)</subfield><subfield code="b">ill. (some col.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from PDF file title page (viewed May 25, 2016)</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"In 2013, 200 million people were infected with malaria, resulting in over 584,000 deaths, with the potential to affect over half the world's population. Such is the widespread nature of malaria that it is increasingly believed only a vaccine will lead to its eradication. Although the first attempt at a vaccine was made a century ago, it is only in the last 30 years that real progress in testing has been made, in the hope of discovering a molecule that can provide long-lasting protection against the disease. In July 2015, GlaxoSmithKline (GSK) announced that after 30 years of research it had received the green light from the European Medicines Agency for the world's first malaria vaccine, RTS, S, for use in African children aged 6 weeks to 17 months. This book chronicles the development of RTS, S — done in collaboration with the Walter Reed Army Institute for Research, the PATH Malaria Vaccine Initiative (MVI) and funded in part by the Bill and Melinda Gates Foundation — as well as previous candidate vaccines. It also focusses on the continuing quest to find more effective vaccines against this continuing health crisis. Finally, it provides an easily understood background on recombinant DNA and monoclonal antibodies and places them in perspective to their contributions to malaria vaccine development. This book serves as a convenient and easily accessible source of information for students, teachers, microbiologists, parasitologists, physicians, clinicians and research funders."--Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Malaria vaccine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Malaria / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Electronic books</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.worldscientific.com/worldscibooks/10.1142/Q0002</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveroeffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-124-WOP</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030031122</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.worldscientific.com/worldscibooks/10.1142/Q0002</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-124-WOP</subfield><subfield code="q">FHN_PDA_WOP</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044633150 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:57:42Z |
| institution | BVB |
| isbn | 9781786340054 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030031122 |
| oclc_num | 988734640 |
| open_access_boolean | |
| owner | DE-92 |
| owner_facet | DE-92 |
| physical | 1 online resource (278 p.) ill. (some col.) |
| psigel | ZDB-124-WOP ZDB-124-WOP FHN_PDA_WOP |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | World Scientific Publishing Europe Ltd |
| record_format | marc |
| spelling | Sherman, Irwin W. Verfasser aut Malaria vaccines the continuing quest Irwin W. Sherman London World Scientific Publishing Europe Ltd c2016 1 online resource (278 p.) ill. (some col.) txt rdacontent c rdamedia cr rdacarrier Title from PDF file title page (viewed May 25, 2016) "In 2013, 200 million people were infected with malaria, resulting in over 584,000 deaths, with the potential to affect over half the world's population. Such is the widespread nature of malaria that it is increasingly believed only a vaccine will lead to its eradication. Although the first attempt at a vaccine was made a century ago, it is only in the last 30 years that real progress in testing has been made, in the hope of discovering a molecule that can provide long-lasting protection against the disease. In July 2015, GlaxoSmithKline (GSK) announced that after 30 years of research it had received the green light from the European Medicines Agency for the world's first malaria vaccine, RTS, S, for use in African children aged 6 weeks to 17 months. This book chronicles the development of RTS, S — done in collaboration with the Walter Reed Army Institute for Research, the PATH Malaria Vaccine Initiative (MVI) and funded in part by the Bill and Melinda Gates Foundation — as well as previous candidate vaccines. It also focusses on the continuing quest to find more effective vaccines against this continuing health crisis. Finally, it provides an easily understood background on recombinant DNA and monoclonal antibodies and places them in perspective to their contributions to malaria vaccine development. This book serves as a convenient and easily accessible source of information for students, teachers, microbiologists, parasitologists, physicians, clinicians and research funders."--Provided by publisher Malaria vaccine Malaria / Treatment Electronic books http://www.worldscientific.com/worldscibooks/10.1142/Q0002 Verlag URL des Erstveroeffentlichers Volltext |
| spellingShingle | Sherman, Irwin W. Malaria vaccines the continuing quest Malaria vaccine Malaria / Treatment Electronic books |
| title | Malaria vaccines the continuing quest |
| title_auth | Malaria vaccines the continuing quest |
| title_exact_search | Malaria vaccines the continuing quest |
| title_full | Malaria vaccines the continuing quest Irwin W. Sherman |
| title_fullStr | Malaria vaccines the continuing quest Irwin W. Sherman |
| title_full_unstemmed | Malaria vaccines the continuing quest Irwin W. Sherman |
| title_short | Malaria vaccines |
| title_sort | malaria vaccines the continuing quest |
| title_sub | the continuing quest |
| topic | Malaria vaccine Malaria / Treatment Electronic books |
| topic_facet | Malaria vaccine Malaria / Treatment Electronic books |
| url | http://www.worldscientific.com/worldscibooks/10.1142/Q0002 |
| work_keys_str_mv | AT shermanirwinw malariavaccinesthecontinuingquest |